APA

Sagers J. E., Beauchamp R. L., Zhang Y., Vasilijic S., Wu L., DeSouza P., Seist R., Zhou W., Xu L., Ramesh V. & Stankovic K. M. (20201123). Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. : Scientific reports.

Chicago

Sagers Jessica E, Beauchamp Roberta L, Zhang Yanling, Vasilijic Sasa, Wu Limeng, DeSouza Patrick, Seist Richard, Zhou Wenjianlong, Xu Lei, Ramesh Vijaya and Stankovic Konstantina M. 20201123. Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. : Scientific reports.

Harvard

Sagers J. E., Beauchamp R. L., Zhang Y., Vasilijic S., Wu L., DeSouza P., Seist R., Zhou W., Xu L., Ramesh V. and Stankovic K. M. (20201123). Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. : Scientific reports.

MLA

Sagers Jessica E, Beauchamp Roberta L, Zhang Yanling, Vasilijic Sasa, Wu Limeng, DeSouza Patrick, Seist Richard, Zhou Wenjianlong, Xu Lei, Ramesh Vijaya and Stankovic Konstantina M. Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. : Scientific reports. 20201123.